Belongs to

• Center for Hematologic Malignancies

Types of Work

["2019"]

[[["Meeting Abstracts",968],["Journal Articles",891],["Book Sections",62],["Conference Papers",12],["Editorials",10],["Research Letters",7],["Reviews",6],["Books Whole",4],["Miscellaneous",3],["Guidelines",2]]]

[1965]

Popular keywords

• adult
• aged
• article
• cyclophosphamide
• doxorubicin
• female
• human
• male
• priority journal
• rituximab

Recent Works

1. Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): A double-blind, randomised, placebo-controlled, phase 3 trial

   Journal Article

   Matasar, M. J.; Capra, M.; Özcan, M.; Lv, F.; Li, W.; Yañez, E.; Sapunarova, K.; Lin, T.; Jin, J.; Jurczak, W; more...
   Lancet Oncology (2021)

   Fulltext@MSK | Save
2. Noninvasive monitoring of mantle cell lymphoma by immunoglobulin gene next-generation sequencing in a phase 2 study of sequential chemoradioimmunotherapy followed by autologous stem-cell rescue

   Journal Article

   Kumar, A.; Bantilan, K. S.; Jacob, A. P.; Park, A.; Schoninger, S. F.; Sauter, C.; Ulaner, G. A.; Casulo, C.; Faham, M.; Kong, K. A.; more...
   Clinical Lymphoma, Myeloma and Leukemia (2021)

   Fulltext@MSK | Save
3. Next generation sequencing of breast implant-associated anaplastic large cell lymphomas reveals a novel STAT3-JAK2 fusion among other activating genetic alterations within the JAK-STAT pathway

   Journal Article

   Quesada, A. E.; Zhang, Y.; Ptashkin, R.; Ho, C.; Horwitz, S.; Benayed, R.; Dogan, A.; Arcila, M. E.
   Breast Journal (2021)

   Fulltext@MSK | Save